1. Home
  2. IHD vs NYXH Comparison

IHD vs NYXH Comparison

Compare IHD & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voya Emerging Markets High Income Dividend Equity Fund

IHD

Voya Emerging Markets High Income Dividend Equity Fund

HOLD

Current Price

$7.18

Market Cap

126.5M

Sector

Finance

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.08

Market Cap

134.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHD
NYXH
Founded
2011
2009
Country
United States
Belgium
Employees
N/A
154
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.5M
134.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
IHD
NYXH
Price
$7.18
$3.08
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
91.9K
22.7K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
10.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$213.98
Revenue Next Year
N/A
$126.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.46
$2.76
52 Week High
$7.59
$8.64

Technical Indicators

Market Signals
Indicator
IHD
NYXH
Relative Strength Index (RSI) 49.89 47.42
Support Level $7.09 $2.80
Resistance Level $7.19 $3.37
Average True Range (ATR) 0.12 0.14
MACD -0.02 0.01
Stochastic Oscillator 10.87 39.80

Price Performance

Historical Comparison
IHD
NYXH

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: